HOME >> MEDICINE >> NEWS
New study provides mixed report card on informed consent to cancer clinical trials

BOSTON While most cancer patients enrolled in clinical trials understand the primary purpose of the research, nearly one quarter of the participants do not realize that clinical trials are conducted mainly to benefit future patients, not themselves. In addition, many patients are unaware that these experimental treatments are not yet proven to be better than available alternatives, according to a study by Boston researchers that appears in the Nov. 24 issue of The Lancet.

These therapeutic misconceptions are common among patients and among some doctors as well even after signing informed consent papers asserting that they fully comprehend the pros and cons of the clinical trials.

In the study, 205 adult cancer patients who had recently enrolled in clinical trials in Boston completed questionnaires about their understanding of the studies. They were participating in Phase I studies looking at safety and side effects, Phase II studies looking for initial evidence of medical benefit, and Phase III studies in which large numbers of patients are randomly assigned to receive either the standard or investigational therapy in order to evaluate which is better.

The researchers found that 71 percent of respondents knew that they might not get any direct medical benefit from the trial, and less than 40 percent recognized that participation might carry additional risk or discomfort when compared with standard therapies.

At the same time virtually all were highly satisfied with the informed consent process, and almost none reported pressure to participate from physicians.

The researchers noted several factors associated with greater knowledge about the trial. Participants who performed better were more likely to have a college education, to speak only English at home, to have read their consent forms carefully, to have had a nurse present during the consent discussion, to have taken time to consider their enrollment decision, and to hav
'"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
22-Nov-2001


Page: 1 2 3

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. UMaine study looks at infants and chronic nighttime crying
3. Chronic pain treatments more effective when taken together, new study shows
4. UNC study: Most N.C. family practitioners engage in unrecognized community service
5. New study in Nature demonstrates protection against cell death during heart attack
6. UCSF study offers insight into human circadian rhythms
7. International breast cancer prevention study launches in the United States and Canada
8. UW study shows blacks and Latinos are more satisfied with physicians of the same race
9. Physicians may not be accurate in their confidence levels of their diagnoses, says Pitt study
10. Advertising by academic medical centers may risk eroding public trust, says study
11. Fat may promote inflammation, new study suggests

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2020)... ... February 11, 2020 , ... R3 Medical Training is now ... 2020 in Las Vegas. The training consists of thread lift placement on real patients ... , PDO thread lifts represent an excellent alternative currently for nonoperative facelift. The procedures ...
(Date:2/10/2020)... , ... February 10, 2020 , ... ... Health and Epidemiology Practice, has been elected president of the Society for ... she and her team develop and implement award-winning, research-driven Federal social marketing campaigns ...
(Date:2/10/2020)... SANTA BARBARA, Calif. (PRWEB) , ... ... ... Palette Life Sciences, Inc., a medical device company dedicated to assisting ... conditions and diseases, today announced the launch of the Solesta® Reimbursement Assistance ...
(Date:2/10/2020)... ... February 10, 2020 , ... American Family Care (AFC), ... aggressively expanding its healthcare network across New England. The first phase includes ... the fast-growing healthcare system. , AFC’s Founder and CEO, Dr. Bruce Irwin , ...
(Date:2/9/2020)... ... 09, 2020 , ... Kim A. Gorgens, Ph.D., ABPP is ... University of Denver. Since 2013, Dr. Gorgens and The Brain Injury Alliance of ... determined that 50-80% of the inmates in Denver County Jails have traumatic brain ...
Breaking Medicine News(10 mins):
(Date:2/10/2020)... (PRWEB) , ... February 10, 2020 , ... A device ... called Hush Buddy -- a patented sleep training system for children, launching today ... their parents. , With the Hush Buddy Sleep System, getting a child to sleep ...
(Date:2/10/2020)... (PRWEB) , ... February 10, 2020 , ... ... healthcare industry from cyberattacks. One way Alpine is securing healthcare is by working ... Medical devices range from external systems, such as drug infusion pumps or patient ...
(Date:2/7/2020)... ... February 07, 2020 , ... Isagenix International ... announced the grand prize winner of its 2020 U.S. IsaBody Challenge® at the ... Washington, was honored onstage in front of thousands of Isagenix independent distributors and ...
Breaking Medicine Technology:
Cached News: